UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions

Oncogene, 2021-03, Vol.40 (9), p.1721-1736

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6980-6990

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice

Molecules (Basel, Switzerland), 2023-12, Vol.28 (24), p.8056

2023

Link zum Volltext

Verfügbarkeit prüfen

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

Journal of experimental & clinical cancer research, 2021-10, Vol.40 (1), p.319-319, Article 319

2021

Link zum Volltext

Verfügbarkeit prüfen

Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists

Angiogenesis (London), 2017-05, Vol.20 (2), p.233-241

2017

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging

Scientific reports, 2016-12, Vol.6 (1), p.39284-39284, Article 39284

2016

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms

The American journal of pathology, 2014-04, Vol.184 (4), p.1050-1061

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts

Cancers, 2020-08, Vol.12 (9), p.2398

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness

Cell death & disease, 2024-05, Vol.15 (5), p.370-370

2024

Link zum Volltext

Verfügbarkeit prüfen

Orthotopic Model of Ovarian Cancer

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1464, p.139

2016

Link zum Volltext

Verfügbarkeit prüfen

ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA

Free radical biology & medicine, 2022-11, Vol.192, p.116-116

2022

Link zum Volltext

Verfügbarkeit prüfen

The ER Stress Response Mediator ERO1 Triggers Cancer Metastasis by Favoring the Angiogenic Switch in Hypoxic Conditions

Free radical biology & medicine, 2020-11, Vol.159, p.S63-S63

2020

Link zum Volltext

Verfügbarkeit prüfen

Deficiency of an endoplasmic reticulum oxidoreductase and activation of protein translation synergistically impair breast tumor resilience

Free radical biology & medicine, 2023-05, Vol.201, p.5-5

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P217: The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P217-P217

2021

Link zum Volltext

Verfügbarkeit prüfen

Syngeneic murine metastasis models: B16 melanoma

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1070, p.131

2014

Link zum Volltext

Verfügbarkeit prüfen

Endoplasmic reticulum oxidoreductin 1‐alpha deficiency and activation of protein translation synergistically impair breast tumour resilience

British journal of pharmacology, 2022-12, Vol.179 (23), p.5180-5195

2022

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response

Molecular cancer therapeutics, 2016-01, Vol.15 (1), p.125-135

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2406: Metabolic phenotype and metastasis in patient-derived ovarian cancer xenografts

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2406-2406

2018

Link zum Volltext

Verfügbarkeit prüfen

PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer

Cancer research (Chicago, Ill.), 2022-04, Vol.82 (7), p.1423-1434

2022

Link zum Volltext

Verfügbarkeit prüfen

Past-in-the-Future. Peak detection improves targeted mass spectrometry imaging

Analytica chimica acta, 2018-12, Vol.1042, p.1-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice

Molecular cancer therapeutics, 2013-10, Vol.12 (10), p.2237-2247

2013

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists

Angiogenesis (London), 2017-05, Vol.20 (2), p.243-244

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4838: Exploiting mitochondrial metabolism to enhance the response to standard of care treatments in ovarian cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4838-4838

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6113: Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6113-6113

2023

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

The European journal of neuroscience, 2007-08, Vol.26 (4), p.843-851

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(145)

Publikationsform

Artikel
(154)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions

Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations

Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling

Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists

Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging

Vascular Endothelial Growth Factor C Promotes Ovarian Carcinoma Progression through Paracrine and Autocrine Mechanisms

Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts

Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness

Orthotopic Model of Ovarian Cancer

ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA

The ER Stress Response Mediator ERO1 Triggers Cancer Metastasis by Favoring the Angiogenic Switch in Hypoxic Conditions

Deficiency of an endoplasmic reticulum oxidoreductase and activation of protein translation synergistically impair breast tumor resilience

Abstract P217: The next generation PARP inhibitor AZD5305 is active in a broad range of pre-clinical models of ovarian cancer

Syngeneic murine metastasis models: B16 melanoma

Endoplasmic reticulum oxidoreductin 1‐alpha deficiency and activation of protein translation synergistically impair breast tumour resilience

Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response

Abstract 2406: Metabolic phenotype and metastasis in patient-derived ovarian cancer xenografts

PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer

Past-in-the-Future. Peak detection improves targeted mass spectrometry imaging

Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice

Erratum to: Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists

Abstract 4838: Exploiting mitochondrial metabolism to enhance the response to standard of care treatments in ovarian cancer

Abstract 6113: Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models

Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

Suchergebnisse filtern